The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms

The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms

S-adenosyl-L-methionine (SAMe) acts as a methyl donor, with dopamine, norepinephrine, and serotonin elevating properties, with potential antidepressant effects. In this study, we evaluated the efficacy of SAMe-vitamin B complex supplement for improving mild and moderate depressive symptoms. The stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hippokratia 2017-01, Vol.21 (3), p.140-143
Hauptverfasser: Djokic, G, Korcok, D, Djordjevic, V, Agic, A, Rankovic, A, Djukic, Dejanovic
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 143
container_issue 3
container_start_page 140
container_title Hippokratia
container_volume 21
creator Djokic, G
Korcok, D
Djordjevic, V
Agic, A
Rankovic, A
Djukic, Dejanovic
description S-adenosyl-L-methionine (SAMe) acts as a methyl donor, with dopamine, norepinephrine, and serotonin elevating properties, with potential antidepressant effects. In this study, we evaluated the efficacy of SAMe-vitamin B complex supplement for improving mild and moderate depressive symptoms. The study included 60 patients diagnosed with depression, with mild or moderate depressive symptoms, randomly allocated into two groups. The study group was treated with SAMe-vitamin B complex while the control group was administered a placebo, once daily for three months. The severity of depressive symptoms was measured by the Hamilton Depression rating scale (HAMD17). We measured the symptoms' severity with the Clinical Global Impression-Severity scale (CGI-S), and the improvement or worsening after treatment with the Clinical Global Impression-Improvement scale (CGI-I). The mean HAMD17 score at zero point refers to moderate depressive symptoms in both groups. We found a statistically significant difference between the two groups regarding the mean HAMD17 and CGI-S scores at three months (p
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6247995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138639099</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-2d42ddc8dd3a951b960d565b1a85603c6ce205e540729af90316d45840cef86e3</originalsourceid><addsrcrecordid>eNpVkE9LxDAUxIso7rr6FSRHL4GkadLkIujiP1jw4Hou2eTVjTRJbdLF_fYWXEVP82CG3zzmqJjTWhEsCVXH002JxBWValacpfROiCiFIKfFjJGqVlUt5oVebwFB24LJCcUWvWBtIcS07_AKe8hbF4MLgHcua-8CukUm-r6DTxQD8q6zSAeLfLQw6AzIQj9ASm4HKO19n6NP58VJq7sEFwddFK_3d-vlI149Pzwtb1a4n57KuLRVaa2R1jKtON0oQSwXfEO15IIwIwyUhAOvSF0q3SrCqLAVlxUx0EoBbFFcf3P7cePBGgh50F3TD87rYd9E7Zr_TnDb5i3uGlFOYyg-Aa4OgCF-jJBy410y0HU6QBxTU1ImBVNEqSl6-bfrt-RnV_YF0tx3DA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2138639099</pqid></control><display><type>article</type><title>The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Djokic, G ; Korcok, D ; Djordjevic, V ; Agic, A ; Rankovic, A ; Djukic, Dejanovic</creator><creatorcontrib>Djokic, G ; Korcok, D ; Djordjevic, V ; Agic, A ; Rankovic, A ; Djukic, Dejanovic</creatorcontrib><description>S-adenosyl-L-methionine (SAMe) acts as a methyl donor, with dopamine, norepinephrine, and serotonin elevating properties, with potential antidepressant effects. In this study, we evaluated the efficacy of SAMe-vitamin B complex supplement for improving mild and moderate depressive symptoms. The study included 60 patients diagnosed with depression, with mild or moderate depressive symptoms, randomly allocated into two groups. The study group was treated with SAMe-vitamin B complex while the control group was administered a placebo, once daily for three months. The severity of depressive symptoms was measured by the Hamilton Depression rating scale (HAMD17). We measured the symptoms' severity with the Clinical Global Impression-Severity scale (CGI-S), and the improvement or worsening after treatment with the Clinical Global Impression-Improvement scale (CGI-I). The mean HAMD17 score at zero point refers to moderate depressive symptoms in both groups. We found a statistically significant difference between the two groups regarding the mean HAMD17 and CGI-S scores at three months (p &lt;0.001) and a significant difference within the study group without an influence by the age or gender. Mean CGI-I score in the study group at three months showed minimally or much improvement while no change or minimal worsening was observed in the control group with significant differences between the groups (p &lt;0.001). Three months of supplementation with SAMe-vitamin B complex is effective for the treatment of mild to moderate depressive symptoms. HIPPOKRATIA 2017, 21(3): 140-143.</description><identifier>ISSN: 1108-4189</identifier><identifier>EISSN: 1790-8019</identifier><identifier>PMID: 30479476</identifier><language>eng</language><publisher>Greece: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</publisher><ispartof>Hippokratia, 2017-01, Vol.21 (3), p.140-143</ispartof><rights>Copyright 2017, Hippokratio General Hospital of Thessaloniki 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247995/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247995/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30479476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Djokic, G</creatorcontrib><creatorcontrib>Korcok, D</creatorcontrib><creatorcontrib>Djordjevic, V</creatorcontrib><creatorcontrib>Agic, A</creatorcontrib><creatorcontrib>Rankovic, A</creatorcontrib><creatorcontrib>Djukic, Dejanovic</creatorcontrib><title>The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms</title><title>Hippokratia</title><addtitle>Hippokratia</addtitle><description>S-adenosyl-L-methionine (SAMe) acts as a methyl donor, with dopamine, norepinephrine, and serotonin elevating properties, with potential antidepressant effects. In this study, we evaluated the efficacy of SAMe-vitamin B complex supplement for improving mild and moderate depressive symptoms. The study included 60 patients diagnosed with depression, with mild or moderate depressive symptoms, randomly allocated into two groups. The study group was treated with SAMe-vitamin B complex while the control group was administered a placebo, once daily for three months. The severity of depressive symptoms was measured by the Hamilton Depression rating scale (HAMD17). We measured the symptoms' severity with the Clinical Global Impression-Severity scale (CGI-S), and the improvement or worsening after treatment with the Clinical Global Impression-Improvement scale (CGI-I). The mean HAMD17 score at zero point refers to moderate depressive symptoms in both groups. We found a statistically significant difference between the two groups regarding the mean HAMD17 and CGI-S scores at three months (p &lt;0.001) and a significant difference within the study group without an influence by the age or gender. Mean CGI-I score in the study group at three months showed minimally or much improvement while no change or minimal worsening was observed in the control group with significant differences between the groups (p &lt;0.001). Three months of supplementation with SAMe-vitamin B complex is effective for the treatment of mild to moderate depressive symptoms. HIPPOKRATIA 2017, 21(3): 140-143.</description><issn>1108-4189</issn><issn>1790-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkE9LxDAUxIso7rr6FSRHL4GkadLkIujiP1jw4Hou2eTVjTRJbdLF_fYWXEVP82CG3zzmqJjTWhEsCVXH002JxBWValacpfROiCiFIKfFjJGqVlUt5oVebwFB24LJCcUWvWBtIcS07_AKe8hbF4MLgHcua-8CukUm-r6DTxQD8q6zSAeLfLQw6AzIQj9ASm4HKO19n6NP58VJq7sEFwddFK_3d-vlI149Pzwtb1a4n57KuLRVaa2R1jKtON0oQSwXfEO15IIwIwyUhAOvSF0q3SrCqLAVlxUx0EoBbFFcf3P7cePBGgh50F3TD87rYd9E7Zr_TnDb5i3uGlFOYyg-Aa4OgCF-jJBy410y0HU6QBxTU1ImBVNEqSl6-bfrt-RnV_YF0tx3DA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Djokic, G</creator><creator>Korcok, D</creator><creator>Djordjevic, V</creator><creator>Agic, A</creator><creator>Rankovic, A</creator><creator>Djukic, Dejanovic</creator><general>SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms</title><author>Djokic, G ; Korcok, D ; Djordjevic, V ; Agic, A ; Rankovic, A ; Djukic, Dejanovic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-2d42ddc8dd3a951b960d565b1a85603c6ce205e540729af90316d45840cef86e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Djokic, G</creatorcontrib><creatorcontrib>Korcok, D</creatorcontrib><creatorcontrib>Djordjevic, V</creatorcontrib><creatorcontrib>Agic, A</creatorcontrib><creatorcontrib>Rankovic, A</creatorcontrib><creatorcontrib>Djukic, Dejanovic</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hippokratia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Djokic, G</au><au>Korcok, D</au><au>Djordjevic, V</au><au>Agic, A</au><au>Rankovic, A</au><au>Djukic, Dejanovic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms</atitle><jtitle>Hippokratia</jtitle><addtitle>Hippokratia</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>21</volume><issue>3</issue><spage>140</spage><epage>143</epage><pages>140-143</pages><issn>1108-4189</issn><eissn>1790-8019</eissn><abstract>S-adenosyl-L-methionine (SAMe) acts as a methyl donor, with dopamine, norepinephrine, and serotonin elevating properties, with potential antidepressant effects. In this study, we evaluated the efficacy of SAMe-vitamin B complex supplement for improving mild and moderate depressive symptoms. The study included 60 patients diagnosed with depression, with mild or moderate depressive symptoms, randomly allocated into two groups. The study group was treated with SAMe-vitamin B complex while the control group was administered a placebo, once daily for three months. The severity of depressive symptoms was measured by the Hamilton Depression rating scale (HAMD17). We measured the symptoms' severity with the Clinical Global Impression-Severity scale (CGI-S), and the improvement or worsening after treatment with the Clinical Global Impression-Improvement scale (CGI-I). The mean HAMD17 score at zero point refers to moderate depressive symptoms in both groups. We found a statistically significant difference between the two groups regarding the mean HAMD17 and CGI-S scores at three months (p &lt;0.001) and a significant difference within the study group without an influence by the age or gender. Mean CGI-I score in the study group at three months showed minimally or much improvement while no change or minimal worsening was observed in the control group with significant differences between the groups (p &lt;0.001). Three months of supplementation with SAMe-vitamin B complex is effective for the treatment of mild to moderate depressive symptoms. HIPPOKRATIA 2017, 21(3): 140-143.</abstract><cop>Greece</cop><pub>SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</pub><pmid>30479476</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1108-4189
ispartof Hippokratia, 2017-01, Vol.21 (3), p.140-143
issn 1108-4189
1790-8019
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6247995
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A52%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20S-adenosyl-L-methionine-vitamin%20B%20complex%20on%20mild%20and%20moderate%20depressive%20symptoms&rft.jtitle=Hippokratia&rft.au=Djokic,%20G&rft.date=2017-01-01&rft.volume=21&rft.issue=3&rft.spage=140&rft.epage=143&rft.pages=140-143&rft.issn=1108-4189&rft.eissn=1790-8019&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2138639099%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2138639099&rft_id=info:pmid/30479476&rfr_iscdi=true